Supernus Pharmaceuticals Inc XNAS: SUPN

Supernus Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: Supernus Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Supernus Pharmaceuticals Inc
Rating: 2.802833375
Author: Trendlyne DVM scores

Value Stock, Under Radar

Download real time

30.76 0.05 (0.16%)

476.3K XNAS Volume

XNAS 17 Apr, 2025 5:30 PM (EDT)

High Financial Strength

66.7 / 100

Affordable Valuation

58.3 / 100

Technically Bearish

32.6 / 100

Value Stock, Under Radar These stocks are strong in quality and valuation, but score weak in technical aspects. Hence, it is better to wait for the stock to change their momentum. View Similar Embed DVM

39

1Yr Price target upside is 26%

5 analysts

Supernus Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Supernus Pharmaceuticals Inc FAQ

How is Supernus Pharmaceuticals Inc today?

Supernus Pharmaceuticals Inc today is trading in the green, and is up by 0.16% at 30.76.

How has Supernus Pharmaceuticals Inc performed historically?

Supernus Pharmaceuticals Inc is currently trading up 0.16% on an intraday basis. In the past week the stock fell -2.87%. stock has been down -18.49% in the past quarter and rose 4.63% in the past year. You can view this in the overview section.